SHAREHOLDERS’ EQUITY (Tables)

12 Months Ended

Dec. 31, 2024

Equity [Abstract]

SCHEDULE OF STOCK OPTION/WARRANTS ACTIVITIES

The following table summarizes the stock option/warrant activities and related information for the years ended December 31, 2024 and 2023:

	Number of Warrants*			Weighted Average Exercise Price		Weighted Average Remaining Term (Years)		Intrinsic Value
As of January 1, 2023		3,137,998		$	0.01		10.00	$	—
Granted		1,781,000			0.0001		10.00		—
Exercised		—			—		—		—
Forfeited		—			—		—		—
As of December 31, 2023		4,918,998		$	0.0064		10.00	$	—
Granted		449,190			0.0001		10.00		—
Additions pursuant to Pono Merger**		12,134,375			11.50		5.00		—
Exercised		(3,137,998	)		0.01		—		—
Forfeited/Cancelled		(2,230,190	)		0.0001		—		—
As of December 31, 2024**		12,134,375		$	11.50		4.80	$	—
Vested and exercisable as of December 31, 2024		12,134,375		$	11.50		4.80	$	—

* The number of Warrants granted to HeartCore was updated to reflect the adjustment upon the consummation of Pono Merger.

** As of December 31, 2024, there were 12,134,375 warrants issued by Pono, prior to Pono Merger, among which 11,500,000 warrants were issued through its initial public offering (“IPO”) (“Public Warrants”) and 634,375 were issued through a private placement (“Placement Warrants”). Each warrant entitles the registered holder to purchase one share of common stock at a price of $11.50 per share at any time commencing on October 17, 2024 until October 17, 2029, or earlier upon redemption or liquidation.